• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2012 Product Image

Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2012

  • Published: October 2012
  • 24 pages
  • Fore Pharma

Fore Pharma announced the results of its Rheumatoid Arthritis patient population study in a new report ‘Global Rheumatoid Arthritis Epidemiology and Patient Flow Analysis - 2012’. The report provides insights into Rheumatoid Arthritis epidemiology, Rheumatoid Arthritis diagnosed patients, and Rheumatoid Arthritis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Rheumatoid Arthritis derived from epidemiological analysis, percentage of patients diagnosed with Rheumatoid Arthritis, and percentage of patients treated with Rheumatoid Arthritis therapy.

The study helps executives estimate Rheumatoid Arthritis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Rheumatoid Arthritis prevalence, Rheumatoid Arthritis diagnosis rate, and Rheumatoid Arthritis treatment rate for the period 2012-2019. The information is presented by leading READ MORE >

1. Rheumatoid Arthritis: Disease Definition
2. Global Rheumatoid Arthritis Patient Flow
2A. Global Rheumatoid Arthritis Prevalence
2B. Global Rheumatoid Arthritis Diagnosed Patients
2C. Global Rheumatoid Arthritis Treated Patients
3. Rheumatoid Arthritis Patient Flow in the US
3A. Rheumatoid Arthritis Prevalence in the US
3B. Rheumatoid Arthritis Diagnosed Patients in the US
3C. Rheumatoid Arthritis Treated Patients in the US
4. Rheumatoid Arthritis Patient Flow in Europe
4A. Rheumatoid Arthritis Prevalence in Europe
4B. Rheumatoid Arthritis Diagnosed Patients in Europe
4C. Rheumatoid Arthritis Treated Patients in Europe
5. Rheumatoid Arthritis Patient Flow in Germany
5A. Rheumatoid Arthritis Prevalence in Germany
5B. Rheumatoid Arthritis Diagnosed Patients in Germany
5C. Rheumatoid Arthritis Treated Patients in Germany
6. Rheumatoid Arthritis Patient Flow in France
6A. Rheumatoid Arthritis Prevalence in France
6B. Rheumatoid Arthritis Diagnosed Patients in France
6C. Rheumatoid Arthritis Treated Patients in France
7. Rheumatoid Arthritis Patient Flow in Spain
7A. Rheumatoid Arthritis Prevalence in Spain
7B. Rheumatoid Arthritis Diagnosed Patients in Spain
7C. Rheumatoid Arthritis Treated Patients in Spain
8. Rheumatoid Arthritis Patient Flow in Italy
8A. Rheumatoid Arthritis Prevalence in Italy
8B. Rheumatoid Arthritis Diagnosed Patients in Italy
8C. Rheumatoid Arthritis Treated Patients in Italy
9. Rheumatoid Arthritis Patient Flow in UK
9A. Rheumatoid Arthritis Prevalence in UK
9B. Rheumatoid Arthritis Diagnosed Patients in UK
9C. Rheumatoid Arthritis Treated Patients in UK
10. Rheumatoid Arthritis Patient Flow in Japan
10A. Rheumatoid Arthritis Prevalence in Japan
10B. Rheumatoid Arthritis Diagnosed Patients in Japan
10C. Rheumatoid Arthritis Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Rheumatoid Arthritis Patient Flow (2012)
Table 2: Global Rheumatoid Arthritis Patient Flow Forecast (2012-2019)
Table 3: Rheumatoid Arthritis Patient Flow in the US (2012)
Table 4: Rheumatoid Arthritis Patient Flow Forecast in the US (2012-2019)
Table 5: Rheumatoid Arthritis Patient Flow in Europe (2012)
Table 6: Rheumatoid Arthritis Patient Flow Forecast in Europe (2012-2019)
Table 7: Rheumatoid Arthritis Patient Flow in Germany (2012)
Table 8: Rheumatoid Arthritis Patient Flow Forecast in Germany (2012-2019)
Table 9: Rheumatoid Arthritis Patient Flow in France (2012)
Table 10: Rheumatoid Arthritis Patient Flow Forecast in France (2012-2019)
Table 11: Rheumatoid Arthritis Patient Flow in Spain (2012)
Table 12: Rheumatoid Arthritis Patient Flow Forecast in Spain (2012-2019)
Table 13: Rheumatoid Arthritis Patient Flow in Italy (2012)
Table 14: Rheumatoid Arthritis Patient Flow Forecast in Italy (2012-2019)
Table 15: Rheumatoid Arthritis Patient Flow in UK (2012)
Table 16: Rheumatoid Arthritis Patient Flow Forecast in UK (2012-2019)
Table 17: Rheumatoid Arthritis Patient Flow in Japan (2012)
Table 18: Rheumatoid Arthritis Patient Flow Forecast in Japan (2012-2019)

Figure 1: Global Rheumatoid Arthritis Patient Flow (2012)
Figure 2: Global Rheumatoid Arthritis Patient Flow Forecast (2012-2019)
Figure 3: Rheumatoid Arthritis Patient Flow in the US (2012)
Figure 4: Rheumatoid Arthritis Patient Flow Forecast in the US (2012-2019)
Figure 5: Rheumatoid Arthritis Patient Flow in Europe (2012)
Figure 6: Rheumatoid Arthritis Patient Flow Forecast in Europe (2012-2019)
Figure 7: Rheumatoid Arthritis Patient Flow in Germany (2012)
Figure 8: Rheumatoid Arthritis Patient Flow Forecast in Germany (2012-2019)
Figure 9: Rheumatoid Arthritis Patient Flow in France (2012)
Figure 10: Rheumatoid Arthritis Patient Flow Forecast in France (2012-2019)
Figure 11: Rheumatoid Arthritis Patient Flow in Spain (2012)
Figure 12: Rheumatoid Arthritis Patient Flow Forecast in Spain (2012-2019)
Figure 13: Rheumatoid Arthritis Patient Flow in Italy (2012)
Figure 14: Rheumatoid Arthritis Patient Flow Forecast in Italy (2012-2019)
Figure 15: Rheumatoid Arthritis Patient Flow in UK (2012)
Figure 16: Rheumatoid Arthritis Patient Flow Forecast in UK (2012-2019)
Figure 17: Rheumatoid Arthritis Patient Flow in Japan (2012)
Figure 18: Rheumatoid Arthritis Patient Flow Forecast in Japan (2012-2019)

Format Properties
Electronic (PDF) The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Hard Copy A printed copy of the report will be shipped to you.
CD ROM The report will be shipped to you in CD ROM format. This is a single user license, allowing one specific user access to the product.
Site License The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.
Enterprisewide The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.
Note: Product cover images may vary from those shown
More

RELATED PRODUCTS

Our Clients

Our clients' logos